165 related articles for article (PubMed ID: 7965705)
1. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.
Collins AC; Luo Y; Selvaag S; Marks MJ
J Pharmacol Exp Ther; 1994 Oct; 271(1):125-33. PubMed ID: 7965705
[TBL] [Abstract][Full Text] [Related]
2. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels.
Pauly JR; Marks MJ; Robinson SF; van de Kamp JL; Collins AC
J Pharmacol Exp Ther; 1996 Jul; 278(1):361-9. PubMed ID: 8764371
[TBL] [Abstract][Full Text] [Related]
3. Genotype influences the development of tolerance to nicotine in the mouse.
Marks MJ; Campbell SM; Romm E; Collins AC
J Pharmacol Exp Ther; 1991 Oct; 259(1):392-402. PubMed ID: 1920127
[TBL] [Abstract][Full Text] [Related]
4. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment.
Pauly JR; Marks MJ; Gross SD; Collins AC
J Pharmacol Exp Ther; 1991 Sep; 258(3):1127-36. PubMed ID: 1890617
[TBL] [Abstract][Full Text] [Related]
5. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
Marks MJ; Stitzel JA; Collins AC
J Pharmacol Exp Ther; 1985 Dec; 235(3):619-28. PubMed ID: 4078726
[TBL] [Abstract][Full Text] [Related]
6. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
Marks MJ; Stitzel JA; Collins AC
J Pharmacol Exp Ther; 1986 Nov; 239(2):358-64. PubMed ID: 3772799
[TBL] [Abstract][Full Text] [Related]
7. Nicotine-induced tolerance and receptor changes in four mouse strains.
Marks MJ; Romm E; Gaffney DK; Collins AC
J Pharmacol Exp Ther; 1986 Jun; 237(3):809-19. PubMed ID: 3712280
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of nicotinic receptor function after chronic nicotine infusion.
Marks MJ; Grady SR; Collins AC
J Pharmacol Exp Ther; 1993 Sep; 266(3):1268-76. PubMed ID: 8371136
[TBL] [Abstract][Full Text] [Related]
9. Genetics of nicotine response in four inbred strains of mice.
Marks MJ; Burch JB; Collins AC
J Pharmacol Exp Ther; 1983 Jul; 226(1):291-302. PubMed ID: 6864548
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the effects of chronic nicotine infusion on tolerance to nicotine and cross-tolerance to ethanol in long- and short-sleep mice.
Collins AC; Romm E; Selvaag S; Turner S; Marks MJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1390-7. PubMed ID: 8371144
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the development of tolerance to ethanol and cross-tolerance to nicotine after chronic ethanol treatment in long- and short-sleep mice.
de Fiebre CM; Collins AC
J Pharmacol Exp Ther; 1993 Sep; 266(3):1398-406. PubMed ID: 8371145
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
13. Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors.
Collins AC; Evans CB; Miner LL; Marks MJ
Pharmacol Biochem Behav; 1986 Jun; 24(6):1767-73. PubMed ID: 3737641
[TBL] [Abstract][Full Text] [Related]
14. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse.
Miner LL; Marks MJ; Collins AC
J Pharmacol Exp Ther; 1986 Dec; 239(3):853-60. PubMed ID: 3795045
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
Marks MJ; Stitzel JA; Romm E; Wehner JM; Collins AC
Mol Pharmacol; 1986 Nov; 30(5):427-36. PubMed ID: 3534542
[TBL] [Abstract][Full Text] [Related]
17. Classical genetic analysis of nicotine-induced seizures and nicotinic receptors.
Miner LL; Marks MJ; Collins AC
J Pharmacol Exp Ther; 1984 Dec; 231(3):545-54. PubMed ID: 6502513
[TBL] [Abstract][Full Text] [Related]
18. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
Bhat RV; Turner SL; Marks MJ; Collins AC
J Pharmacol Exp Ther; 1990 Oct; 255(1):187-96. PubMed ID: 2213555
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
Marks MJ; Farnham DA; Grady SR; Collins AC
J Pharmacol Exp Ther; 1993 Feb; 264(2):542-52. PubMed ID: 8437106
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes.
Lu Y; Grady S; Marks MJ; Picciotto M; Changeux JP; Collins AC
J Pharmacol Exp Ther; 1998 Nov; 287(2):648-57. PubMed ID: 9808692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
